Mónika Patricia Consuegra Rodríguez

Dr. Mónika Patricia Consuegra Rodríguez

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Travel Medicine and Infectious Disease
Verified
Journal Article
Closed access
MRMónika Patricia Consuegra Rodríguez
Mónika Patricia Consuegra Rodríguez
DHDiana Meliza Hidalgo-Zambrano
Diana Meliza Hidalgo-Zambrano
HVHeriberto Vásquez-Serna
Heriberto Vásquez-Serna
CJCarlos Eduardo Jimenez-Canizales
Carlos Eduardo Jimenez-Canizales
EPEsteban Parra-Valencia
Esteban Parra-Valencia
Alfonso J. Rodriguez-MoralesAlfonso J. Rodriguez-Morales
Alfonso J. Rodriguez-Morales

24 March 2023 in Science Advances
Verified
Journal Article
Closed access
MRMakeda L. Robinson
Makeda L. Robinson
DGDavid R. Glass
David R. Glass
VDVeronica Duran
Veronica Duran
OROlga Lucia Agudelo Rojas
Olga Lucia Agudelo Rojas
ASAna Maria Sanz
Ana Maria Sanz
SEShirit Einav
Shirit Einav
Approximately 5 million dengue virus–infected patients progress to a potentially life-threatening severe dengue (SD) infection annually. To identify the immune features and temporal dynamics underlying SD progression, we performed deep immune profiling by mass cytometry of PBMCs collected longitudinally from SD progressors (SDp) and uncomplicated dengue (D) patients. While D is characterized by early activation of innate immune responses, in SDp there is rapid expansion and activation of IgG-secreting plasma cells and memory and regulatory T cells. Concurrently, SDp, particularly children, demonstrate increased proinflammatory NK cells, inadequate expansion of CD16 + monocytes, and high expression of the FcγR CD64 on myeloid cells, yet a signature of diminished antigen presentation. Syndrome-specific determinants include suppressed dendritic cell abundance in shock/hemorrhage versus enriched plasma cell expansion in organ impairment. This study reveals uncoordinated immune responses in SDp and provides insights into SD pathogenesis in humans with potential implications for prediction and treatment.

22 September 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
MRMakeda L. Robinson
Makeda L. Robinson
DGDavid R. Glass
David R. Glass
VDVeronica Duran
Veronica Duran
OROlga Lucia Agudelo Rojas
Olga Lucia Agudelo Rojas
ASAna Maria Sanz
Ana Maria Sanz
SEShirit Einav
Shirit Einav
Summary: Approximately five million dengue virus-infected patients, particularly children, progress to a potentially life-threatening severe dengue (SD) infection annually. To identify the immune features and temporal dynamics underlying SD progression, we performed deep immune profiling by mass cytometry of PBMCs collected longitudinally from SD progressors (SDp) and uncomplicated dengue (D) patients. While D is characterized by early activation of innate immune responses, in SDp there is rapid expansion and activation of IgG-secreting plasma cells and memory and regulatory T cells. Concurrently, SDp, particularly children, demonstrate increased proinflammatory NK cells, inadequate expansion of CD16 + monocytes, and high expression of the FcγR, CD64 on myeloid cells, yet diminished antigen presentation. Syndrome-specific determinants include suppressed dendritic cell abundance in shock/hemorrhage vs. enriched plasma cell expansion in organ impairment. This study reveals uncoordinated immune responses in SDp and provides insights into SD pathogenesis in humans with potential implications for prediction and treatment.

1 August 2010 in Revista de Salud Pública
Verified
Journal Article
Closed access
PDF file
EQEliana M Quintero-Roa
Eliana M Quintero-Roa
RORicardo Ortiz-Serrano
Ricardo Ortiz-Serrano
MOMiguel E Ochoa-Vera
Miguel E Ochoa-Vera
MRMónika Patricia Consuegra Rodríguez
Mónika Patricia Consuegra Rodríguez
COCarol A Oliveros
Carol A Oliveros
To evaluate the socio-demographic characteristics of females who admitted to having previously undergone induced abortion who were attended at Hospital Local del Norte in Bucaramanga from the viewpoint of distributive justice. This was a descriptive, cross-sectional study of a convenience sample of patients who consulted the Hospital Local del Norte's Emergency Gynaecology-Obstetrics Service in Bucaramanga between March 1/2008 and February 28/2009 who had a diagnosis of abortion in any of their presentations. The sample involved 93 patients, 16 of whom accepted that they had undergone an induced abortion. Factors associated with the event were belonging to a low socioeconomic stratum, lacking adequate health care and education in family planning, lack of a stable partner or that their relationship was dysfunctional and that the couple had pressured for an induced abortion for economic reasons or that their desire for parenting had already been satisfied. Contrasting these results with existing health legislation bioethics from a social justice in health viewpoint revealed that current legislation is deficient in both its coverage and extension to educational activity regarding sexual and reproductive health. Enabling patients to enjoy their sexuality responsibly and improving opportunities for access to better economic options may reduce induced abortions in the population living in Bucaramanga's northern commune.

28 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SYSophie Yacoub
Sophie Yacoub
ADAnastasiia Demidova
Anastasiia Demidova
XCXin Hui S Chan
Xin Hui S Chan
AAAli Ajam
Ali Ajam
DBDina Baimukhambetova
Dina Baimukhambetova
DMDaniel Munblit
Daniel Munblit
Dengue, caused by any one of four distinct virus serotypes, is the most rapidly spreading mosquito-borne viral disease worldwide. It is a primary arboviral infection with increasing global incidence, driven by climate change, urbanisation, and the expanding range of Aedes mosquito vectors. Despite growing research interest, outcome and measurement instrument heterogeneity in dengue clinical trials remains high, limiting comparability and evidence synthesis. This project aimed to develop a globally relevant Core Outcome Measurement Set (COMS) for use in dengue clinical trials through international consensus.This consensus study followed COMET and COS-STAD guidelines and was conducted in two phases. Phase I focused on developing a core outcome set (COS) through six steps: (1) a systematic literature review; (2) qualitative interviews with people with lived experience of dengue; (3) review by the management group and steering committee; (4) a two-round modified Delphi survey and structured online consensus meetings to finalise the COS for ‘hospitalised’ and ‘early’ stages of dengue. Input from critical care experts informed recommendations for the ‘ICU/HDU’ COS. Phase II involved: (5) targeted review of outcome measurement instruments; and (6) a hybrid international consensus workshop to finalise the COMS.The agreed COMS for ‘hospitalised’ dengue included seven outcomes; the ‘early’ COS includes these plus four more. For critical care trials, use of existing ICU-specific COS was recommended. Unified definitions were developed for nine clinician-reported outcomes.The DEN-CORE COMS provides a consensus-based framework for harmonising outcome selection and measurement in dengue trials, improving comparability and supporting policy and clinical decision-making.

9 November 2023 in medRxiv
Verified
Preprint
Open access
PDF file
RRRosa Margarita Gelvez Ramirez
Rosa Margarita Gelvez Ramirez
MRMónika Patricia Consuegra Rodríguez
Mónika Patricia Consuegra Rodríguez
MEMaría Isabel Estupiñan
María Isabel Estupiñan
ARAdriana Torres Rangel
Adriana Torres Rangel
VHVíctor Mauricio Herrera
Víctor Mauricio Herrera
LCLuis Ángel Villar Centeno
Luis Ángel Villar Centeno
Dengue has a broad spectrum of syndromic presentations, making clinical diagnosis difficult in regions where acute febrile syndrome has multiple etiologies. Rapid tests for detecting NS1 and IgM are broadly proposed for the early diagnosis of dengue; however, their implementation in primary care settings is inconsistent, and the relevance of IgM detection in this context has not been firmly established. Our study aimed to describe the experience of validating an NS1-IgM rapid test in primary care settings in Bucaramanga, Colombia, during a dengue epidemic (2018 to 2020). We tested blood samples from 568 patients with a clinical diagnosis of dengue using the Bioline Dengue Duo rapid test and RT-PCR as a reference to estimate sensitivity, specificity, and positive and negative predictive values (SE, SP, PPV, and NPV, respectively). The prevalence of infection was 32.9% (95%CI: 29.1, 36.8), whereas SE and SP were 83.4% and 72.7% for NS1 without statistical heterogeneity across disease duration. NS1’s PPV and NPV were 60.0% and 89.9% at the observed prevalence. Our results show that NS1 and IgM rapid tests (POCT) are feasible in the primary care setting. The contribution of the NS1 test was indisputable, with high-performance levels far superior to those of the IgM test. The NS1+IgM combination did not offer a significant advantage over NS1 alone.